iBio, Inc.
IBIO Real Time Price USDRecent trades of IBIO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by IBIO's directors and management
Government lobbying spending instances
-
$70,000 Apr 18, 2022 Issue: Health Issues
-
$30,000 Apr 09, 2022 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Jan 16, 2022 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Health Issues
-
$70,000 Jan 13, 2022 Issue: HEALTH ISSUES
-
$30,000 Oct 20, 2021 Issue: Health Issues Medical/Disease Research/Clinical Labs Budget/Appropriations
-
$70,000 Oct 19, 2021 Issue: HEALTH ISSUES
-
$20,000 Jul 26, 2021 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations
-
$10,000 Jul 20, 2021 Issue: Health Issues
-
$30,000 Jul 17, 2021 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Health Issues
-
$70,000 Jul 08, 2021 Issue: HEALTH ISSUES
-
$20,000 Apr 20, 2021 Issue: Health Issues
-
$20,000 Apr 19, 2021 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$30,000 Apr 19, 2021 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Health Issues
-
$70,000 Apr 12, 2021 Issue: HEALTH ISSUES
-
$20,000 Jan 20, 2021 Issue: None
-
$70,000 Jan 18, 2021 Issue: HEALTH ISSUES
-
$10,000 Jan 16, 2021 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$40,000 Oct 20, 2020 Issue: None
-
$70,000 Oct 16, 2020 Issue: HEALTH ISSUES
-
$40,000 Jul 20, 2020 Issue: None
-
$70,000 Jul 15, 2020 Issue: HEALTH ISSUES
-
$70,000 Apr 17, 2020 Issue: HEALTH ISSUES
-
$70,000 Jan 21, 2020 Issue: HEALTH ISSUES
-
$60,000 Apr 22, 2019 Issue: Health Issues
-
$60,000 Jan 22, 2019 Issue: Health Issues
-
$40,000 Jan 20, 2019 Issue: Health Issues
-
$60,000 Jul 20, 2018 Issue: Health Issues
-
$40,000 Jul 20, 2018 Issue: Health Issues
-
$60,000 Apr 20, 2018 Issue: Health Issues
-
$40,000 Apr 17, 2018 Issue: Health Issues
-
$60,000 Jan 18, 2018 Issue: Health Issues
-
$10,000 Jan 10, 2018 Issue: Health Issues
-
$10,000 Oct 23, 2017 Issue: Health Issues
-
$60,000 Oct 20, 2017 Issue: Health Issues
-
$60,000 Jul 20, 2017 Issue: Health Issues
-
$60,000 Apr 20, 2017 Issue: Health Issues
-
$60,000 Jan 19, 2017 Issue: Health Issues
-
$60,000 Jan 20, 2016 Issue: Health Issues
-
$60,000 Oct 20, 2015 Issue: Health Issues
-
$60,000 Jul 16, 2015 Issue: Health Issues
-
$15,000 Apr 23, 2015 Issue: Health Issues
-
$70,000 Apr 25, 2014 Issue: None
-
$80,000 Jan 27, 2014 Issue: Medical/Disease Research/Clinical Labs
-
$75,000 Oct 16, 2013 Issue: Medical/Disease Research/Clinical Labs
-
$70,000 Jul 25, 2013 Issue: Medical/Disease Research/Clinical Labs
-
$60,000 Jul 24, 2013 Issue: Medical/Disease Research/Clinical Labs
-
$8,000 Jul 19, 2010 Issue: Budget/Appropriations
-
$10,000 Apr 13, 2010 Issue: Budget/Appropriations
-
$15,000 Jan 12, 2010 Issue: Budget/Appropriations
-
$15,000 Oct 20, 2009 Issue: Budget/Appropriations
-
$40,000 Feb 13, 2003 Issue: Health Issues Budget/Appropriations
-
$40,000 Aug 20, 2002 Issue: Health Issues Transportation Budget/Appropriations
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of IBIO in WallStreetBets Daily Discussion
Recent insights relating to IBIO
Recent picks made for IBIO stock on CNBC
ETFs with the largest estimated holdings in IBIO
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IBIO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.